Back to results

Texas A&M University

Pleozymes Decrease Cellular Senescence in Friedreich’s Ataxia

Abstract

dc:description.abstract

Friedreich's Ataxia (FRDA) is a disorder that decreases levels of the mitochondrial protein Frataxin. Frataxin deficiency disrupts mitochondrial electron transport chain and iron homeostasis, leading to electron leakage, superoxide production, and reduced ATP. DNA damage and production of reactive oxygen species may cause senescence, a physiologic mechanism whereby a proliferating cell undergoes cell cycle arrest and can undergo a secretory inflammatory phenotype. Here, we tested a new FRDA therapy using nanoparticles with versatile enzymatic properties we term, "Pleozymes." Pleozymes are synthesized from the oxidation of activated charcoal (OAC), generating 3 nM discs, which act as pleiotropic redox mediators for mitochondrial electron transport and act as superoxide dismutase mimetics. OACs permit covalent bonding of molecules, such as Polyethylene-glycol, for enhanced biodistribution (PEG-OAC Pleozymes) and therapeutics, here we add the iron chelator deferoxamine (DEF-OAC-PEG Pleozymes). We hypothesize that pleozymes, especially DEF-OAC-PEGs, because of both mitochondrial dysfunction and iron dyshomeostasis, will reduce senescence in FRDA cells. AHI and FRDA cell lines increase senescence without pleozyme treatment with different patterns. Without pleozymes, senescence increased in FRDA cell lines following two patterns: increased levels after the first passage or plateauing after the second passage. Without pleozymes, senescence increased in AHI cell lines but not as prominently until the fourth passage. With pleozymes, senescence decreased in all FRDA cell lines by passage 2 or 3, DEF-OAC-PEG showing a greater decrease than the PEG-OAC in 4 out of 5 cell lines (p < 0.01-0.05 vs. untreated), and equal in the fifth cell line (p < 0.01 vs. untreated). In cells from matched AHI cell lines, OAC treatment reduced senescence but only by passage 4, with the DEF and non-DEF OAC equal or favoring PEG-OAC (p < 0.01 vs. untreated). Results suggest pleozymes decrease senescence in FRDA cell lines compared to AHIs, likely due to mitochondrial oxidative injuries in FRDAs. DEF-OAC-PEGs were generally superior to PEG-OACs in FRDA cell lines, as hypothesized, while PEG-OACs were favored in AHIs. DEFOAC-PEG's therapeutic potential may be explained by deferoxamine's iron chelation, which aids in FRDA's iron dyshomeostasis, given their Frataxin deficiency. This study provides a new therapeutic pathway for Friedreich's Ataxia.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Masters
Discipline thesis:degree_discipline
Medical Sciences
Department thesis:degree_department
School of Medicine
Grantor
Texas A&M University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Perli, Elias
Advisor dc:contributor.advisor
  • Huston, David
Committee member dc:contributor.committeemember
  • Hegde, Muralidhar
ORCID person:identifier.orcid

Subjects

dc:subject × 1

Rights

Language dc:language.iso
English

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1969.1/1595467

Chain of custody

source
Harvested from
Texas A&M University
Base URL
oaktrust.library.tamu.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Perli, Elias. Pleozymes Decrease Cellular Senescence in Friedreich’s Ataxia. Masters thesis, Texas A&M University, 2025. https://hdl.handle.net/1969.1/1595467